Internal Medicine · Sugarland, FO
NPI
1306903265
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1235 Lakepoint Pkwy Suite 101
Sugarland, FO
Phone (281) 980-2233
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
2,316 services
Medicare patients, 2024
285
Average age 71
Drug cost, 2024
$904K
12,112 prescriptions
Company payments, 2025
$912
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viren N Shah was code 99214 (office e&m - established), 599 times for 232 patients. In total Viren N Shah billed 2,316 services in 28 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 599 | 232 | $83.50 | $50K |
| 99213 Office E&M - Established | Office | 530 | 227 | $59.60 | $32K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 262 | 76 | $24.83 | $6,506 |
| 99497 Care Management/Coordination | Office | 243 | 241 | $54.43 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 222 | 222 | $127.19 | $28K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 137 | 137 | $18.37 | $2,517 |
| 90653 Vaccine Product | Office | 33 | 33 | $81.82 | $2,700 |
| G0008 Administration of influenza virus vaccine | Office | 33 | 33 | $31.03 | $1,024 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 32 | 25 | $153.01 | $4,896 |
| 99407 Behavioral Health Services | Office | 32 | 12 | $26.86 | $860 |
| 95251 Test - Miscellaneous | Office | 31 | 14 | $25.28 | $784 |
| 99215 Office E&M - Established | Office | 28 | 24 | $117.85 | $3,300 |
| 99212 Office E&M - Established | Office | 18 | 15 | $37.49 | $675 |
| 93000 Electrocardiogram | Office | 15 | 15 | $9.64 | $145 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 13 | 13 | $162.21 | $2,109 |
By year: 2022 $211K for 3,087 services; 2023 $143K for 2,129 services; 2024 $152K for 2,316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Viren N Shah prescribed most often to Medicare patients was Atorvastatin Calcium, with 972 prescriptions and refills. In total Viren N Shah wrote 12,112 Medicare prescriptions that cost $904K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 972 | 2,674 | 281 | $11K |
| Rosuvastatin Calcium Generic | 708 | 1,951 | 228 | $18K |
| Levothyroxine Sodium Generic | 639 | 1,641 | 161 | $5,217 |
| Amlodipine Besylate Generic | 592 | 1,615 | 181 | $3,932 |
| Metformin Hcl Generic | 528 | 1,397 | 153 | $3,235 |
| Losartan Potassium Generic | 456 | 1,231 | 141 | $5,032 |
| Famotidine Generic | 251 | 642 | 86 | $3,856 |
| Metoprolol Succinate Generic | 233 | 651 | 74 | $3,853 |
| Ibandronate Sodium Generic | 227 | 604 | 81 | $12K |
| Carvedilol Generic | 206 | 522 | 56 | $1,918 |
| Nifedipine Er Nifedipine | 197 | 497 | 55 | $6,354 |
| Tamsulosin Hcl Generic | 182 | 522 | 61 | $2,587 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 167 | 456 | 47 | $3,522 |
| Lisinopril Generic | 151 | 411 | 43 | $910 |
| Glimepiride Generic | 149 | 423 | 49 | $1,452 |
Brand drugs: 1,145 claims; generic drugs: 10,887 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Viren N Shah $912 ($912 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $158.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $158 |
| Novo Nordisk Inc NVO | 7 | $146 |
| GlaxoSmithKline, LLC. GSK | 5 | $89.9 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81.23 |
| Lilly USA, LLC LLY | 4 | $68.74 |
| Pfizer Inc. PFE | 3 | $56.38 |
| Vivus LLC | 3 | $53.09 |
| Abbvie Inc. ABBV | 2 | $42.08 |
| Abbott Laboratories ABT | 2 | $38.56 |
| Exact Sciences Corporation EXAS | 2 | $37.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.